CSF2 and colorectal carcinoma: A CRC vaccine composed of irradiated, allogeneic human CRC cell lines along with GM-CSF-producing bystander cells and cyclophosphamide in a phase 1 study showed safety and feasibility in patients with metastatic CRC (10).